Unverified50% confidenceEventExact time
The FDA approved a blood test for use in the auxiliary assessment of Alzheimer's disease.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
8/30/2026
First Seen
Valid until: 11/28/2026
Sources
Related Entities
Related Claims
UnverifiedAlzheimer's disease blood tests indirectly reflect pathological changes in the brain by measuring biomarkers such as plasma p-tau protein and amyloid ratios.73% similarUnverifiedThe intended use of the blood test approved by the FDA is 'auxiliary assessment' rather than a standalone diagnostic tool.68% similarUnverifiedFDA批准的AI诊断工具IDx-DR用于检测糖尿病视网膜病变，要求医生对AI诊断结果进行最终确认67% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/823834API
curl https://kongchang.com/api/v1/knowledge/claims/823834MCP
get_claim(id=823834)